Emergency Medicine Doctors in Delaware Medicare Details, Address, Contact
220 Emergency Medicine doctors found. Showing 121 - 140
 Dr. Kirti Patel, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown-stanton Rd, Newark, DE 19718 Phone: 302-733-1041 Fax: 302-733-1068 |
Donnita M Scott, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4755 Ogletown-stanton Rd, Newark, DE 19718 Phone: 302-733-1000 Fax: 302-733-1633 |
 Nathan Potter, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-4176 |
Taemin Kim, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 703-447-1112 |
George R Zlupko, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown-stanton Rd, Newark, DE 19718 Phone: 302-733-1000 Fax: 302-733-1633 |
Ellen Curtis Finney, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Cchs Emergency Department, Newark, DE 19718 Phone: 302-733-3901 |
Jesse Liou, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd Ste 5a43, Newark, DE 19718 Phone: 302-623-0188 Fax: 302-733-5640 |
Brian J Levine, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 Fax: 302-733-1633 |
Dr. Scott Gary Schmidt Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1800 |
Matthew James Rizzotti, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 |
Daniel Bruce Cummings, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-755-1700 |
Kyle Richard Haniszewski, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 |
Katherine Greco, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 |
Nicholas Colazzo, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 |
Dr. Erin Elizabeth Watson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Department Of Emergency Medicine, Newark, DE 19718 Phone: 302-203-2222 |
Dr. Stephen Joseph Koczirka Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Suite 1071, Department Of Emergency Medicine, Newark, DE 19718 Phone: 302-733-3901 |
John F Madden, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 Fax: 302-733-1633 |
Heather Auerbach, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1042 |
Eric Lieu, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 |
Dr. Stefanie E Golebiewski-manchin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1042 |
News Archive
Quorum sensing data presented at the North American Cystic Fibrosis Conference by Neem Biotech
Neem Biotech, the Welsh-based fundamental Research and Development arm of the Zaluvida group of life science companies, was pleased to present the work into development of a novel mode of action as an adjunct to existing antibiotics at the North American Cystic Fibrosis Conference Indiana, USA from 2nd November 2017 to 4th of November 2017.
FDA grants Orphan Drug Designation to YM BioSciences' JAK1/2 inhibitor
YM BioSciences Inc., announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration has granted Orphan Drug Designation to the Company's highly-selective JAK1/2 inhibitor, CYT387, for the treatment of myelofibrosis, a chronic debilitating unmet medical need, in which a patient's bone marrow is replaced by scar tissue, and for which treatment options are limited or unsatisfactory.
New minimally invasive surgery for lung cancer reduces post-operative pain
Generally, after traditional open-chest surgery for lung cancer, patients may experience a significant amount of pain and spend up to a week in the hospital followed by months recovering.
SIRIUS supports single-agent daratumumab in refractory multiple myeloma
Phase II trial results show that daratumumab monotherapy elicits responses and has a favourable adverse event profile in heavily-pretreated, refractory multiple myeloma patients.
› Verified 5 days ago